Jeppe Øvlesen

Board member and investor

📍 Copenhagen, Capital Region, Denmark🔄 Updated September 2026💼 14 investments📅 21 years investing🗓 Last invested Jan 2014
VC🌍 Denmark
14
Total investments
2
Early stage
0
Mid stage
0
Late stage
21y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
2014
ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation.
Board Member
2012
Monsenso is an innovative technology company offering a digital health solution to help optimise the treatment of mental disorders. Our mission is to empower healthcare providers, researchers, and individuals, as well as to help societies overcome the burden of mental illness. Our solution provides a detailed overview of a patient’s mental health through the collection of behavioral data and self-monitoring. Based on continued research and development, our team is committed to developing comprehensive solutions that fit seamlessly into the lives of individuals, increasing the quality and efficacy of their treatment. For more information visit www.monsenso.com
Board Member
2005
NordEnergie Renewables A/S is a renewables & environment company based out of 45Amaliegade, Copenhagen, Capital Region of Denmark, Denmark.
Experience · 16 entries
All (16)
Investments (14)
Board (14)
2019
Chairman
Jan 2019
The HG Energy Group focuses on the R&D of clean energy products and continuous innovation in our high-quality solar module, keep improving our enhanced Busbar technology and efficiency to meet our valued customers requirements. In the near future, our products will cover Mono Perc, N & P-type Topcon and HGT solar technologies. We provide flexible, smart solar eco-solutions that can improve our customers wide range applications of solar projects.
2014
Board Member
2014
ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation.
2013
Perfusion Tech
Board Member
2013
US Enovacore
Board Member
2013
US Enovacore
Board Member
2013
Show all 16 entries ↓
Investment activity
2005–2014 · 14 investments
20051200612007220114201222013320141
Recent (last 2 years)Earlier